Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Telmisartan + Metoprolol Succinate ER Tablet is an allopathic medicine The correct dosage of StayHappi Telmisartan + Metoprolol Succinate ER Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Telmisartan + Metoprolol Succinate ER Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Telmisartan + Metoprolol Succinate ER Tablet is used -
Severe
Common
Is the use of StayHappi Telmisartan + Metoprolol Succinate ER Tablet safe for pregnant women?
StayHappi Telmisartan + Metoprolol Succinate ER Tablet has many dangerous side effects in pregnant women. If you are pregnant, do not consume StayHappi Telmisartan + Metoprolol Succinate ER Tablet without medical advice.
Is the use of StayHappi Telmisartan + Metoprolol Succinate ER Tablet safe during breastfeeding?
StayHappi Telmisartan + Metoprolol Succinate ER Tablet does not show any side effects in breastfeeding women.
What is the effect of StayHappi Telmisartan + Metoprolol Succinate ER Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking StayHappi Telmisartan + Metoprolol Succinate ER Tablet. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of StayHappi Telmisartan + Metoprolol Succinate ER Tablet on the Liver?
StayHappi Telmisartan + Metoprolol Succinate ER Tablet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of StayHappi Telmisartan + Metoprolol Succinate ER Tablet on the Heart?
Side effects of StayHappi Telmisartan + Metoprolol Succinate ER Tablet rarely affect the heart.
StayHappi Telmisartan + Metoprolol Succinate ER Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Telmisartan + Metoprolol Succinate ER Tablet unless your doctor advises you to do so -
Is this StayHappi Telmisartan + Metoprolol Succinate ER Tablet habit forming or addictive?
No, there is no any evidence that StayHappi Telmisartan + Metoprolol Succinate ER Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking StayHappi Telmisartan + Metoprolol Succinate ER Tablet as you may feel sleepy.
Is it safe?
Yes, but take StayHappi Telmisartan + Metoprolol Succinate ER Tablet only as per medical advice.
Is it able to treat mental disorders?
StayHappi Telmisartan + Metoprolol Succinate ER Tablet is unable to treat or cure mental disorders.
Interaction between Food and StayHappi Telmisartan + Metoprolol Succinate ER Tablet
Due to a lack of research, nothing can be said about the consequences of taking StayHappi Telmisartan + Metoprolol Succinate ER Tablet together with food.
Interaction between Alcohol and StayHappi Telmisartan + Metoprolol Succinate ER Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking StayHappi Telmisartan + Metoprolol Succinate ER Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850